Acutus Medical of Carlsbad, California, having won FDA clearance for its AcQMap last fall, has announced that the system has been used for the first time in the United States. The system’s novel catheter uses ultrasound and electrical tissue conduction mapping to provide a novel electrophysiologic live view inside the heart. Both the mechanics of the organ and its electrical activity can be seen simultaneously, which provides a combined, in-context look at the hearts functionality.
The company has also begun a clinical study in Canada and Europe to assess the AcQMap during atrial fibrillation retreatment procedures.
“Enabling physicians to see complex, irregular arrhythmias in real-time should provide important new insights and enable truly personalized and individualized ablation therapy planning. We hope that this unique capability, combined with the ability to quickly re-map after each ablation, will lead the way to further improvements in clinical outcomes for patients suffering from complex arrhythmias,” in a statement said Vince Burgess, Chairman, President and CEO, at Acutus Medical. “Together with institutions across the country, we hope to transform the lives of people suffering from complex arrhythmias through our innovative technology and are pleased that U.S. patients now have access to AcQMap.”
Here’s a video from Acutus Medical explaining the AcQMap:
Via: Acutus Medical…